These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31112944)

  • 1. Psychosocial Impact of Dysarthria: The Patient-Reported Outcome as Part of the Clinical Management.
    Atkinson-Clement C; Letanneux A; Baille G; Cuartero MC; Véron-Delor L; Robieux C; Berthelot M; Robert D; Azulay JP; Defebvre L; Ferreira J; Eusebio A; Moreau C; Pinto S
    Neurodegener Dis; 2019; 19(1):12-21. PubMed ID: 31112944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysarthria impact profile: development of a scale to measure psychosocial effects.
    Walshe M; Peach RK; Miller N
    Int J Lang Commun Disord; 2009; 44(5):693-715. PubMed ID: 18821230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis.
    Mackenzie C; Green J
    Int J Lang Commun Disord; 2009; 44(4):401-20. PubMed ID: 19294553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial impact of Parkinson's disease-associated dysarthria: Cross-cultural adaptation and validation of the Dysarthria Impact Profile into European Portuguese.
    Cardoso R; Guimarães I; Santos H; Loureiro R; Domingos J; Abreu D; Gonçalves N; Pinto S; Ferreira JJ
    Geriatr Gerontol Int; 2018 May; 18(5):767-774. PubMed ID: 29372587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dysarthria impact profile: a preliminary French experience with Parkinson's disease.
    Letanneux A; Walshe M; Viallet F; Pinto S
    Parkinsons Dis; 2013; 2013():403680. PubMed ID: 23766926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.
    Feenaughty L; Tjaden K; Weinstock-Guttman B; Benedict RHB
    Am J Speech Lang Pathol; 2018 Aug; 27(3):1051-1065. PubMed ID: 30054632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living with acquired dysarthria: the speaker's perspective.
    Walshe M; Miller N
    Disabil Rehabil; 2011; 33(3):195-203. PubMed ID: 20735274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural intervention effects in dysarthria following stroke: communication effectiveness, intelligibility and dysarthria impact.
    Mackenzie C; Lowit A
    Int J Lang Commun Disord; 2007; 42(2):131-53. PubMed ID: 17365091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shorter Sentence Length Maximizes Intelligibility and Speech Motor Performance in Persons With Dysarthria Due to Amyotrophic Lateral Sclerosis.
    Allison KM; Yunusova Y; Green JR
    Am J Speech Lang Pathol; 2019 Feb; 28(1):96-107. PubMed ID: 31072158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intelligibility of dysarthric speech: perceptions of speakers and listeners.
    Walshe M; Miller N; Leahy M; Murray A
    Int J Lang Commun Disord; 2008; 43(6):633-48. PubMed ID: 18608608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward phonetic intelligibility testing in dysarthria.
    Kent RD; Weismer G; Kent JF; Rosenbek JC
    J Speech Hear Disord; 1989 Nov; 54(4):482-99. PubMed ID: 2811329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Psychometric Properties of the Voice Handicap Index in People With Parkinson's Disease.
    Guimaraes I; Cardoso R; Pinto S; Ferreira JJ
    J Voice; 2017 Mar; 31(2):258.e13-258.e18. PubMed ID: 27397112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysarthria and Friedreich's ataxia: what can intelligibility assessment tell us?
    Blaney B; Hewlett N
    Int J Lang Commun Disord; 2007; 42(1):19-37. PubMed ID: 17365084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysarthria following acute ischemic stroke: Prospective evaluation of characteristics, type and severity.
    De Cock E; Oostra K; Bliki L; Volkaerts AS; Hemelsoet D; De Herdt V; Batens K
    Int J Lang Commun Disord; 2021 May; 56(3):549-557. PubMed ID: 33580596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prosodic Improvement in Persons with Parkinson Disease Receiving SPEAK OUT!® Voice Therapy.
    Boutsen F; Park E; Dvorak J; Cid C
    Folia Phoniatr Logop; 2018; 70(2):51-58. PubMed ID: 29996139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired dysarthria in conversation: methods of resolving understandability problems.
    Bloch S; Wilkinson R
    Int J Lang Commun Disord; 2011; 46(5):510-23. PubMed ID: 21899669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.
    Miller N; Allcock L; Jones D; Noble E; Hildreth AJ; Burn DJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1188-90. PubMed ID: 17400592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.